Israel Englander Ani Pharmaceuticals Inc Call Options Transaction History
Millennium Management LLC
- $192 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ANIP
# of Institutions
241Shares Held
20MCall Options Held
19.9KPut Options Held
12.8K-
Black Rock Inc. New York, NY2.66MShares$235 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.28MShares$113 Million0.0% of portfolio
-
Global Alpha Capital Management Ltd.862KShares$76.2 Million3.45% of portfolio
-
State Street Corp Boston, MA716KShares$63.3 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT700KShares$61.8 Million1.62% of portfolio
About ANI PHARMACEUTICALS INC
- Ticker ANIP
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 17,426,000
- Market Cap $1.54B
- Description
- ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...